HYBRID EVENT: Join us in person in London, UK or attend virtually from anywhere.

6th Edition of International Conference on Tissue Engineering and Regenerative Medicine

September 28-30 | London, UK

September 28 -30, 2026 | London, UK

Crispr Cas9

Crispr Cas9

CRISPR-Cas9 (Clustered Regularly Interspaced Short Palindromic Repeats and CRISPR-associated protein 9) is a revolutionary genome editing technology that enables precise modification of DNA sequences within living organisms. Originally derived from the bacterial immune system, CRISPR-Cas9 allows researchers to selectively target and edit specific genes by utilizing RNA molecules to guide the Cas9 protein to the desired genomic location. This technology has transformed genetic research, offering unprecedented accuracy, efficiency, and simplicity in gene editing. CRISPR-Cas9 has diverse applications, ranging from basic scientific research to potential therapeutic interventions for genetic disorders. In research, it allows the investigation of gene function, regulation, and the study of diseases with a genetic basis. Moreover, CRISPR-Cas9 holds promise in developing novel treatments for genetic conditions by correcting or modifying defective genes. The versatility of CRISPR-Cas9 extends to agriculture, where it can be employed to enhance crop traits or develop disease-resistant plants. While CRISPR-Cas9 offers remarkable opportunities, ethical considerations surround its use, particularly in human germline editing. The ability to edit the human germline raises ethical questions about unintended consequences and the potential for designer babies. Scientists and ethicists continue to engage in discussions to establish responsible guidelines for the application of CRISPR-Cas9. In summary, CRISPR-Cas9 represents a groundbreaking tool in genetic engineering, offering unprecedented precision in gene editing with transformative implications for biological research, medicine, and agriculture. Ongoing advancements and ethical considerations will shape the responsible and beneficial application of this revolutionary technology.

Committee Members
Speaker at Tissue Engineering and Regenerative Medicine 2026 - Kunal Mitra

Kunal Mitra

Florida Tech, United States
Speaker at Tissue Engineering and Regenerative Medicine 2026 - Ivan Kelnar

Ivan Kelnar

Institute of Macromolecular Chemistry, Czech Academy of Sciences, Czech Republic
Speaker at Tissue Engineering and Regenerative Medicine 2026 - Lucie Bacakova

Lucie Bacakova

Institute of Physiology of the Czech Academy of Sciences, Czech Republic
TERMC 2026 Speakers
Speaker at Tissue Engineering and Regenerative Medicine 2026 - Gokarneshan Narayanan

Gokarneshan Narayanan

SSM College of Engineering (Formerly), India
Speaker at Tissue Engineering and Regenerative Medicine 2026 - Sandeep Shrivastava

Sandeep Shrivastava

Datta Meghe Institute of Medical Sciences, India
Speaker at Tissue Engineering and Regenerative Medicine 2026 - Vasiliki E Kalodimou

Vasiliki E Kalodimou

European University-Cyprus Ltd, Cyprus
Speaker at Tissue Engineering and Regenerative Medicine 2026 - Aradhana Kasimsetty

Aradhana Kasimsetty

National Center for Advancing Translational Sciences (NCATS), National Institutes of Health (NIH), United States

Submit your abstract Today

Youtube
Watsapp